Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Development of Oral Cancer Diagnostic Receives Backing

Published: Tuesday, July 22, 2014
Last Updated: Tuesday, July 22, 2014
Bookmark and Share
Zilico Ltd has received funding from the Technology Strategy Board, the UK’s innovation agency.

Zilico Ltd has begun development work on a medical device which uses Electrical Impedance Spectroscopy (EIS) in the detection and diagnosis of oral cancer following funding from the Technology Strategy Board, the UK’s innovation agency.  

The two awards are from the Biomedical Catalyst Feasibility and Smart Funds. The funds will help support an in-depth analysis of the UK market, deliver a product specification for an oral diagnostic device and a protocol for a multi-centre trial.

The funding builds on the proof-of-concept study that was recently presented and is part of a wider development programme leading to a multi-centre trial. The awards will help support development projects worth £160k.

Zilico’s lead product ZedScan uses its proprietary EIS technology to detect dysplasia and cancer of the cervix. As oral cancer follows a similar neoplastic pathway to that of the cervix, EIS can be used to detect changes in the oral epithelium as cells progress from normal to precancerous and then to cancerous.

The University of Sheffield’s Professor of Oral Medicine, Martin Thornhill, presented on the use of EIS in the detection and diagnosis of oral cancer and dysplasia to the most influential group of oral medicine experts in America last year.

Professor Thornhill’s presentation, Use of Impedance Spectroscopy to Detect Potentially Malignant Oral Lesions, was delivered at the 67th Annual Meeting of the American Academy of Oral Medicine (AAOM) in San Antonio, Texas. The study on 50 patients was the result of a collaboration between the University of Sheffield, Sheffield Teaching Hospitals NHS Foundation Trust and Zilico Ltd.

The presentation abstract was published in the Oral Surgery, Oral Pathology, Oral medicine and Oral Radiology Journal in September 2013.  The full paper describing the study has been accepted for publication in the peer-reviewed Journal of Nanomedicine.

Zilico Chief Executive Sameer Kothari said: “We are delighted to have secured this funding, which will allow us to build on the proof-of concept study and positive feedback the data received at last year’s AAOM.

“We are now well placed to further develop the device and assess it in a multi-centre clinical study. There is a clear clinical need for a more accurate diagnostic in the patient pathway.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NICE Publishes Medtech Innovation Briefing on ZedScan
MIB to provide objective information on device and diagnostic technologies to aid local decision-making.
Saturday, February 21, 2015
Scientific News
Adoption of Three Dimensional Culture Models May Save Lives
Physiologically relevant cell models can detect chronic hepatotoxicity early in the drug discovery process.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
NASA's DNA Sequencing in Space is a Success
DNA has been sequenced in space for the first time ever for the Biomolecule Sequencer investigation, using the MinION sequencing device.
Major Pathogen of Barley Decoded
A team of scientists studying the fungus that causes Ramularia leaf spot have sequenced and explored its genome.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Shark Fins & Meat Contain High Levels of Neurotoxins Linked to Alzheimer’s Disease
UM research team says restricting shark consumption protects human health and shark populations.
Worms Point Way Toward Viral Strategies
Rice University wins NIH grant to study how nematodes handle gastrointestinal viruses.
Molecule Prevents Effect of Chemotherapy
Danish researchers from Aarhus University Hospital and Aarhus University have made a possible breakthrough in the treatment of colorectal cancer.
How The 'Police' Of The Cell World Deal With 'Intruders' And The 'Injured'
Findings may help discover new targets to manipulate inflammation.
Bringing Artificial Enzymes Closer to Nature
Scientists have developed an artificaiak metalloenzyme that catalyses a natural reaction within cells that has no natural equivalent.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!